EOLS News & Events

Evolus announced that the commercial launch of Estyme, its injectable hyaluronic acid gel collection in Europe, is scheduled for May 16th, marking the company's entry into the international dermal filler market. The Estyme collection includes four injectable HA gels that will cover a wide range of applications. The collection includes Estyme Smooth and Estyme Form, which are currently marketed in the United States under the brand Evolysse, along with the debut of two products including Estyme Lips and the flagship product in the line, Estyme Sculpt, which is expecting U.S. FDA approval later this year. Developed for restoring mid-face volume, Estyme Sculpt addresses one of the most in-demand treatment areas in aesthetics. Designed by Symatese, the innovative Cold-X technology helps preserve the natural structure of the HA molecule, providing long-lasting, natural-looking results. The commercial launch follows the successful CE Mark certification under the European Medical Device Regulation.

Reports Q1 revenue $73.1M, consensus $72.17M. "We started 2026 with a second consecutive quarter of positive Adjusted EBITDA, delivering profitability in what is seasonally our lowest revenue quarter," said David Moatazedi, President and Chief Executive Officer of Evolus. "This performance reflects continued strength of the business and the benefit from structural improvements we implemented in 2025. Importantly, achieving profitability in the first quarter further reinforces the durability of our operating model and our confidence in achieving full-year profitability in 2026."

Stocks ended the day higher after data showed the U.S. service economy expanded at the fastest pace since mid-2022 while a price index hit an almost one-year low, taking attention off geopolitical headlines for a session. The conflict in the Middle East has entered its fifth day and while there have been reports Iran has made indirect contact about potential talks, feeding some risk appetite, uncertainty around the durability of any de-escalation continues to drive positioning and the energy complex continues to influence the broader market's direction. Crude oil prices wavered near $75 per barrel in a volatile session.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Applecontinued a week of new product launches, with the latest being thelaptopGooglesaid it isbrought against the company over its flagship AI product GeminiModernaentered into aworth up to $2.25B with a subsidiary of Roivant Sciencesand Arbutus BiopharmaRoss Storesreported a, raised its quarterly dividend and approved a new two-year $2.55B stock repurchase planFordreportedyear-over-year in February to 149,962 vehicles2. WALL STREET CALLS:BofA reinstated Teslaat Buy as the "Targetat Telsey Advisory and to Market Perform at BernsteinPiper Sandlerat NorthlandLegalZoomat BarclaysFirst Solarat GLJ Research on weak guidance3. AROUND THE WEB:AmazonPublisher Services, which helps websites run ad auctions, is exploring offering technology to help other apps and sites sell ads in AI chatbots, The Information saysOpenAI is developing an alternative to Microsoft'sGitHub, The Information reportsMetais testing a shopping research feature for its AI chatbot that will allow requests for product suggestions, Bloomberg saysThe White House is debating if it will allow Tencentto maintain stakes in popular video game groups, FT reportsDOJ investigating possible price fixing in fertilizer market, Bloomberg reports4. MOVERS:SCHMIDgained afterthe first specialized InfinityLine H+ systemEvolusadvanced afterand providing guidance for FY26Babcock & Wilcoxincreased afterand announcing it has received full notice to proceed on a $2.4B design-build agreement with Base ElectronIndie Semiconductorfell after filing to sell $150M ofGitLabclosed lower afterand authorizing a $400M share repurchase program5. EARNINGS/GUIDANCE:Abercrombie & Fitchreportedand provided guidance for Q1 and FY26Holleyreported, with EPS missing consensusDycomreported Q4 results, withon "strong fourth quarter performance"Bath & Body Worksreported, with EPS and revenue beating consensusBayerreportedand provided guidance for FY26INDEXES:The Dow rose 238.14, or 0.49%, to 48,739.41, the Nasdaq gained 290.79, or 1.29%, to 22,807.48, and the S&P 500 advanced 52.87, or 0.78%, to 6,869.50.

Markets are higher near noon as geopolitical headlines remain at the center of the tape. The conflict in the Middle East has entered its fifth day and while there have been reports Iran has made indirect contact about potential talks, feeding some risk appetite, uncertainty around the durability of any de-escalation continues to drive positioning. The energy complex continues to influence the broader market's direction as the easing in the recent oil price surge has provided a tailwind, but traders are still cautious amid the ongoing Iran conflict.Global equity markets outside the U.S. are showing stress, with Asian markets taking a particularly severe hit. South Korea's benchmark index experienced one of its largest historical selloffs and other major Asian indices like Japan's Nikkei and Taiwan's TAIEX traded materially lower as well.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Applecontinued a week of, with the latest being the MacBook Neo laptopA subsidiary of Roivant Sciencesand Arbutus Biopharmaentered into a COVID-19with Modernaworth up to $2.25BRoss Storesreported a, raised its quarterly dividend and approved a new two-year $2.55B stock repurchase planCoreWeaveannounced awith Perplexity to support its inference workloadsFordwere down 5.5% year-over-year in February to 149,962 vehicles2. WALL STREET CALLS:BofATeslaat Buy as the "leader" of the next era of mobilityTargetto Outperform at Telsey Advisory and to Market Perform at BernsteinPiper Sandlerto Outperform at NorthlandLegalZoomto Underweight at BarclaysFirst Solarto Hold at GLJ Research on weak guidance3. AROUND THE WEB:AmazonPublisher Services, which helps websites run ad auctions, is exploring offering technology to help other apps and sites sell ads in AI chatbots, The Information saysOpenAI is developing an alternative to Microsoft'sGitHub, The Information reportsMetais testing a shopping research feature for its AI chatbot that will allow requests for product suggestions, Bloomberg saysThe White House is debating if it will allow Tencentto maintain stakes in popular video game groups, FT reportsDraftKing'sstrategy to become a prediction market leader is to copy the formula it used to dominate the online sports betting industry, WSJ reports4. MOVERS:SCHMIDgains in New York afterthe first specialized InfinityLine H+ systemEvolushigher afterand providing guidance for FY26Babcock & Wilcoxincreases afterand announcing it has received full notice to proceed on a $2.4B design-build agreement with Base ElectronIndie Semiconductorfalls after filing to sell $150M ofGitLablower afterand authorizing a $400M share repurchase program5. EARNINGS/GUIDANCEAbercrombie & Fitchand provided guidance for Q1 and FY26Holleywith EPS missing consensusDycom, with CEO Dan Peyovich commenting, "Our strong fourth quarter performance closed a record year for Dycom"Bath & Body Works, with EPS and revenue beating consensusBayerand provided guidance for FY26INDEXES:Near midday, the Dow was up 0.68%, or 329.64, to 48,830.91, the Nasdaq was up 1.46%, or 329.81, to 22,846.51, and the S&P 500 was up 0.87%, or 59.51, to 6,876.14.